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Introduction
Long-term studies of remission rates in juvenile idiopathic
arthritis (JIA) are few and difficult to compare because of
different definitions of remission.
Objectives
To assess disease activity in a previously studied cohort
of JIA patients after 30 years of disease duration and
reveal predictors of persistently active disease.
Methods
A total of 259 patients with JIA, first referred to our hos-
pital from 1980 to1985, were reexamined clinically after
median 15 years of disease duration, and by mailed ques-
tionnaires after median 23 years. These patients were
invited to attend the present study. All patients were
assessed by questionnaires, and those with signs of active
disease after 15, 23 and/or 30 years were invited to a clin-
ical reexamination. Inactive disease and remission were
defined according to the recently developed preliminary
criteria for clinical remission in JIA. Logistic regression
analyses were used to assess predictors of active disease.
Results
One hundred and seventy-one patients (67%) were
included in the study. They were examined after a median
of 30 (range 21-40) years of disease duration, median age
was 39 (range 28-45) years and 74% were females. After
30 years, 59% of the patients were in clinical remission off
medication, 7% were in remission on medication and 34%
had persistently active disease compared with 57%, 10%,
and 33%, respectively, after 15 years.
Thirty-seven of 57 patients (65%) with active disease at
15 years follow-up had active disease at 30 years follow-up,
and 20 patients (35%) went into remission on or off medi-
cation. Eighty-four of 97 patients (87%) in remission off
medication remained in this category from 15 to 30 years
follow-up. Patients in remission on medication at 15 years
(n = 17) tended to flare or go into remission off medica-
tion. In total 121/171 patients (71%) had an unchanged
category of disease activity from 15 to 30 years follow-up.
Predictors of persistently active disease at 30 years follow-
up were: being diagnosed with a JIA subgroup other than
persistent oligoarticular and systemic JIA (OR 4.1, 95%CI
1.5-11.5, p = 0.006), being DR1 positive (OR 8.3, 95%CI
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Table 1
Disease activity at 15 years follow-up Not in remission at 30 years Remission on med. at 30 years Remission off med. at 30 years
Not in remission 57 (33%) 37 9 11
Remission on med. 17 (10%) 9 2 6
Remission off med. 97 (57%) 12 1 84
Total 171 (100%) 58 (34%) 12 (7%) 101 (59%)
med.: medication
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2.3-30.3, p = 0.001), a short duration of total time in remis-
sion (OR 9.0, 95% CI 3.0-26.7, p < 0.001), and not being in
remission at 15 years follow-up (OR 13.7, 95%CI 4.9-38.4,
p < 0.001), Nagelkerkes R2 = 65%.
Conclusion
The overall remission rates were stable between 15 and 30
years, even though one third of the patients changed cate-
gory of disease activity. JIA subgroup, genetic factors and
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